Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03109418 · ClinicalTrials.gov registry record · Phase 2
Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea
A Phase 2 study, sponsored by University of Alabama at Birmingham.
- Terminated
- Registry status
- Phase 2
- Development phase
- 9
- Enrollment target
NCT03109418: Clinical Trial Phase 2 study, sponsored by University of Alabama at Birmingham.
NCT03109418 is a Phase 2 study that was terminated before completion, run by University of Alabama at Birmingham. The registered enrollment target is 9 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03109418, a Phase 2 study, was terminated before completion, sponsored by University of Alabama at Birmingham.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 9 participants
- Enrollment target
Study Summary
The aim of this study is to substantially reduce overall postoperative morbidity and mortality associated with obstructive sleep apnea.
Primary Outcome
Visual Analog Scale pain rating
Interventions
- PROCEDURE Control
- DRUG Ketamine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2016-06-02 |
| Est. Completion | 2018-09-12 |
| Phase | Phase 2 |
Why NCT03109418 stopped before completion
NCT03109418 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT03109418 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03109418 about?
NCT03109418 is a clinical study titled "Intraoperative Low-dose Ketamine Infusion for Patients With Obstructive Sleep Apnea". The aim of this study is to substantially reduce overall postoperative morbidity and mortality associated with obstructive sleep apnea.
What is the current status of trial NCT03109418?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 9 participants. The study started on 2016-06-02. Estimated completion is 2018-09-12.
What interventions are being tested in trial NCT03109418?
The interventions under investigation include: Control (PROCEDURE), Ketamine (DRUG).
Who is sponsoring clinical trial NCT03109418?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03109418's enrollment target sits among peer trials
9 1989th of 2000 higher than 11 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI